Literature DB >> 22273600

Mn loaded apoferritin as an MRI sensor of melanin formation in melanoma cells.

Ibolya Szabó1, Simonetta Geninatti Crich, Diego Alberti, Ferenc K Kálmán, Silvio Aime.   

Abstract

Mn(III)-loaded apoferritin is promptly reduced to Mn(II)-apoferritin by the oxidation of L-DOPA to melanin. The process is nicely witnessed by a marked relaxation enhancement of water proton relaxation rate that has been detected both in cultured melanoma cells and in tumor animal models. This journal is © The Royal Society of Chemistry 2012

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22273600     DOI: 10.1039/c2cc17801j

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  6 in total

1.  Advanced Functional Nanomaterials for Theranostics.

Authors:  Haoyuan Huang; Jonathan F Lovell
Journal:  Adv Funct Mater       Date:  2016-11-07       Impact factor: 18.808

2.  Ultrasensitive electrochemical immunoassay for melanoma cells using mesoporous polyaniline.

Authors:  M U Anu Prathap; Carlos Iván Rodríguez; Omer Sadak; Jiehao Guan; Vijayasaradhi Setaluri; Sundaram Gunasekaran
Journal:  Chem Commun (Camb)       Date:  2018-01-18       Impact factor: 6.222

Review 3.  Environmentally responsive MRI contrast agents.

Authors:  Gemma-Louise Davies; Iris Kramberger; Jason J Davis
Journal:  Chem Commun (Camb)       Date:  2013-10-28       Impact factor: 6.222

4.  Porphyrin-substituted H-NOX proteins as high-relaxivity MRI contrast agents.

Authors:  Michael B Winter; Piper J Klemm; Christine M Phillips-Piro; Kenneth N Raymond; Michael A Marletta
Journal:  Inorg Chem       Date:  2013-02-08       Impact factor: 5.165

5.  Redox-activated manganese-based MR contrast agent.

Authors:  Galen S Loving; Shreya Mukherjee; Peter Caravan
Journal:  J Am Chem Soc       Date:  2013-03-19       Impact factor: 15.419

Review 6.  Ferritin - a multifaceted protein scaffold for biotherapeutics.

Authors:  Na Kyeong Lee; Seongeon Cho; In-San Kim
Journal:  Exp Mol Med       Date:  2022-10-03       Impact factor: 12.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.